Nippon Begin Period Cash Flow from 2010 to 2025

NAM-INDIA   537.75  7.95  1.50%   
Nippon Life's Begin Period Cash Flow is increasing over the years with very volatile fluctuation. Begin Period Cash Flow is expected to dwindle to about 232.3 M. Begin Period Cash Flow is the amount of cash Nippon Life India has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
244.5 M
Current Value
232.3 M
Quarterly Volatility
458.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nippon Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nippon Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 318.4 M, Interest Expense of 75.3 M or Selling General Administrative of 919.1 M, as well as many indicators such as . Nippon financial statements analysis is a perfect complement when working with Nippon Life Valuation or Volatility modules.
  
This module can also supplement various Nippon Life Technical models . Check out the analysis of Nippon Life Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Nippon Stock

Nippon Life financial ratios help investors to determine whether Nippon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nippon with respect to the benefits of owning Nippon Life security.